Managing Shingles (HZ) in Elderly with Topical Application of Acyclovir 5 mg and Increasing Immunity with Matily Herbal Drink – A Case Study

Article ID

3690X

Managing Shingles (HZ) in Elderly with Topical Application of Acyclovir 5 mg and Increasing Immunity with Matily Herbal Drink – A Case Study

John T. Eapen
John T. Eapen
DOI

Abstract

Varicella zoster virus (VZV) causes chickenpox, a self-limited disease with disseminated skin lesions that occurs mostly in childhood. It usually persists symtomatically in the dorsal root ganglia of anyone who has had chickenpox. It reactivates from its dormant state and travel along the sensory nerve, causing vesicular lesions in the dermatome supplied by that nerve in about 25% of people who had chickenpox in their childhood. These lesions, known as Herpes zoster or shingles and it causes a painful eruption of a rash, usually unilaterally. It occurs more frequently in older adults and immunocompromised individuals (1). HZ afflicts millions of older adults worldwide and causes significant suffering because of acute and chronic pain, or postherpetic neuralgia (PHN) (2). It is believed that the potential risk factors for HZ are aging and suppression of cellular immunity (1,2,3). They treat HZ with topical application of Acyclovir 5% cream. In severe cases, they prescribe Acyclovir 800 mg 5 times daily for 7 to 10 days and, they recommend taking plenty of water along with medication (4). Therefore, it is for patients with normal cardiac and kidney function.

Managing Shingles (HZ) in Elderly with Topical Application of Acyclovir 5 mg and Increasing Immunity with Matily Herbal Drink – A Case Study

Varicella zoster virus (VZV) causes chickenpox, a self-limited disease with disseminated skin lesions that occurs mostly in childhood. It usually persists symtomatically in the dorsal root ganglia of anyone who has had chickenpox. It reactivates from its dormant state and travel along the sensory nerve, causing vesicular lesions in the dermatome supplied by that nerve in about 25% of people who had chickenpox in their childhood. These lesions, known as Herpes zoster or shingles and it causes a painful eruption of a rash, usually unilaterally. It occurs more frequently in older adults and immunocompromised individuals (1). HZ afflicts millions of older adults worldwide and causes significant suffering because of acute and chronic pain, or postherpetic neuralgia (PHN) (2). It is believed that the potential risk factors for HZ are aging and suppression of cellular immunity (1,2,3). They treat HZ with topical application of Acyclovir 5% cream. In severe cases, they prescribe Acyclovir 800 mg 5 times daily for 7 to 10 days and, they recommend taking plenty of water along with medication (4). Therefore, it is for patients with normal cardiac and kidney function.

John T. Eapen
John T. Eapen

No Figures found in article.

John T. Eapen. 2020. “. Global Journal of Medical Research – F: Diseases GJMR-F Volume 20 (GJMR Volume 20 Issue F8): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Classification
GJMR-F Classification: NLMC Code: QW 540
Keywords
Article Matrices
Total Views: 2192
Total Downloads: 1135
2026 Trends
Research Identity (RIN)
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Managing Shingles (HZ) in Elderly with Topical Application of Acyclovir 5 mg and Increasing Immunity with Matily Herbal Drink – A Case Study

John T. Eapen
John T. Eapen

Research Journals